COVID-19 Resource Center

Innovation is key to emerging from the COVID-19 pandemic and protecting that innovation with IP is essential. Here, we present our COVID-19-related information.

As the world grapples with the COVID-19 pandemic, our attorneys are helping clients navigate the complex intellectual property issues involved in developing testing, treatments, and vaccines, as well as related products and services to combat the disease. Additionally, our thought leaders are publishing articles, leading panel discussions, and serving as sources to the media in order to contribute to the global conversation about solutions to the crisis.

Of course, innovation is key to emerging from the pandemic, and protecting that innovation is essential. Here, for your easy reference, we present our content related to COVID-19 and intellectual property considerations. Please do not hesitate to contact us for further information and/or to discuss your specific IP questions and concerns.

Related Resources

In the News

WTO Waiver Spurs In-House Fears of Broader Deals

Managing IP June 29, 2022

In the News

Moderna Delays Bid for Covid Shot Patent Disputed by NIH

Bloomberg December 17, 2021

Bylined Articles

Waiving Covid-19 Vaccine Patents Won’t Solve the Global Need

Bloomberg Law August 17, 2021

In the News

How 7 IP Firms Weathered The COVID-19 Pandemic

Law360 December 21, 2020

In the News

Six IP Firms Reveal Post-COVID Management Plans

Managing Intellectual Property July 24, 2020

In the News

Esquire @ Home: When Law Firms Go Remote

Washington Lawyer July 2, 2020

Bylined Articles

USPTO COVID-19 Prioritized Trademark Examination Program

Sterne, Kessler, Goldstein & Fox P.L.L.C. June 30, 2020

In the News

Trademark Cases Drop as Pandemic Fuels Uncertainties

Bloomberg Law June 17, 2020

Webinar

The Impact of COVID-19 on Trademark Prosecution and Examination

May 28, 2020 12:00 PM - 1:00 PM PST

Global Patent Prosecution

Global Patent Prosecution – May 2020

May 26, 2020

Bylined Articles

WIPO’s COVID-19 IP Policy Tracker

Sterne, Kessler, Goldstein & Fox P.L.L.C. May 26, 2020

Bylined Articles

Joint Research Considerations As Biotech Responds To Virus

Law360 April 27, 2020

In the News

Remote Court Arguments Pose Challenges, New Routines for Lawyers

Bloomberg Law April 23, 2020

In the News

The post-pandemic workplace will hardly look like the one we left behind

The Washington Post April 23, 2020

Bylined Articles

Vaccine R&D and Economic Impact of COVID-19 Pandemic

ACC Docket April 22, 2020

Webinar

Innovation in the Age of COVID-19

April 14, 2020 11:00 AM - 1:00 PM PST

In the News

Webinar on Innovation in Age of COVID-19

Patent Docs April 11, 2020

In the News

3D Printing Ingenuity During Coronavirus Comes With IP Risks

Bloomberg Law April 1, 2020

Press Release

Sterne Kessler 100% Operational — Seamless Services for Our Clients

Sterne, Kessler, Goldstein & Fox P.L.L.C. March 16, 2020

Bylined Articles

Patenting Compounds, Compositions, and Methods for Viral Infections

Bloomberg Law March 11, 2020

Bylined Articles

Vaccine IP Under Microscope With Coronavirus Outbreak

Law360 March 4, 2020

Bylined Articles

Grab Some Limes? What to do When Your Brand Goes Viral – and Not in a Good Way

Sterne, Kessler, Goldstein & Fox January 31, 2020